These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16320633)

  • 21. Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons.
    Boschi A; Martini P; Pasquali M; Uccelli L
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1402-1412. PubMed ID: 28443689
    [No Abstract]   [Full Text] [Related]  

  • 22. Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.
    Hohn A; Zimmermann K; Schaub E; Hirzel W; Schubiger PA; Schibli R
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):145-50. PubMed ID: 18174878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclotron Production of Non-conventional Theranostic Radionuclides and Radiopharmaceuticals.
    Jalilian AR; Engle JW; Osso JA
    Curr Radiopharm; 2021; 14(4):304-305. PubMed ID: 34784857
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target development for diversified irradiations at a medical cyclotron.
    Spellerberg S; Scholten B; Spahn I; Bolten W; Holzgreve M; Coenen HH; Qaim SM
    Appl Radiat Isot; 2015 Oct; 104():106-12. PubMed ID: 26142809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of radionuclides in therapy].
    Vucina J; Han R
    Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of production yields, radionuclidic purity and hotcell shielding of SPECT and PET radionuclides produced by proton irradiation in variable energy 30 MeV cyclotrons--Part 67Ga.
    Adam-Rebeles R; Van den Winkel P; De Vis L
    Appl Radiat Isot; 2007 Sep; 65(9):995-1013. PubMed ID: 17624794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron-emitting isotopes produced on biomedical cyclotrons.
    McQuade P; Rowland DJ; Lewis JS; Welch MJ
    Curr Med Chem; 2005; 12(7):807-18. PubMed ID: 15853713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective production of ⁶⁵Zn with a PET cyclotron.
    Lucconi G; Cicoria G; Pancaldi D; Malizia C; Marengo M
    Appl Radiat Isot; 2012 Aug; 70(8):1590-4. PubMed ID: 22732395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies.
    Matarrese M; Bedeschi P; Scardaoni R; Sudati F; Savi A; Pepe A; Masiello V; Todde S; Gianolli L; Messa C; Fazio F
    Appl Radiat Isot; 2010 Jan; 68(1):5-13. PubMed ID: 19736021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of radiopharmaceuticals for PET investigations].
    Mikecz P; Tóth G; Horváth G; Lehel S; Kovács Z; Pribóczki E; Boros I; Miklovicz T; Márián T
    Orv Hetil; 2002 May; 143(21 Suppl 3):1240-2. PubMed ID: 12077905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary study for the production of high specific activity radionuclides for nuclear medicine obtained with the isotope separation on line technique.
    Borgna F; Ballan M; Corradetti S; Vettorato E; Monetti A; Rossignoli M; Manzolaro M; Scarpa D; Mazzi U; Realdon N; Andrighetto A
    Appl Radiat Isot; 2017 Sep; 127():214-226. PubMed ID: 28649019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A strategy for intensive production of molybdenum-99 isotopes for nuclear medicine using CANDU reactors.
    Morreale AC; Novog DR; Luxat JC
    Appl Radiat Isot; 2012 Jan; 70(1):20-34. PubMed ID: 21816619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility studies towards future self-sufficient supply of the (99)Mo-(99m)Tc isotopes with Japanese accelerators.
    Nakai K; Takahashi N; Hatazawa J; Shinohara A; Hayashi Y; Ikeda H; Kanai Y; Watabe T; Fukuda M; Hatanaka K
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):413-21. PubMed ID: 25504230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic assessment to estimate and minimize neutron dose rates received by occupationally exposed individuals at cyclotron facilities.
    Reina LC; Silva AX; Suita JC; Souza MI; Facure A; Silva JC; Furlanetto JA; Rebello W
    Appl Radiat Isot; 2010 Mar; 68(3):489-95. PubMed ID: 20060307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At.
    Henriksen G; Messelt S; Olsen E; Larsen RH
    Appl Radiat Isot; 2001 May; 54(5):839-44. PubMed ID: 11258534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiopharmaceuticals in PET imaging.
    Duncan K
    J Nucl Med Technol; 1998 Dec; 26(4):228-34; quiz 242. PubMed ID: 9884933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG.
    Awasthi V; Watson J; Gali H; Matlock G; McFarland A; Bailey J; Anzellotti A
    Appl Radiat Isot; 2014 Jul; 89():167-75. PubMed ID: 24650573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioisotopes: The medical testing crisis.
    Van Noorden R
    Nature; 2013 Dec; 504(7479):202-4. PubMed ID: 24336269
    [No Abstract]   [Full Text] [Related]  

  • 40. New measurements and evaluation of excitation functions for (p,xn), (p,pxn) and (p,2pxn) reactions on (133)Cs up to 70MeV proton energy.
    Tárkányi F; Hermanne A; Takács S; Ditrói F; Király B; Yamazaki H; Baba M; Mohammadi A; Ignatyuk AV
    Appl Radiat Isot; 2010 Jan; 68(1):47-58. PubMed ID: 19854656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.